CT features and outcomes of newly developed pulmonary lesions in patients with coronavirus disease 2019 (COVID-19)

0Citations
Citations of this article
27Readers
Mendeley users who have this article in their library.

Abstract

Background: In patients with coronavirus disease 2019 (COVID-19) pneumonia, whether new pulmonary lesions will continue to develop after treatment was unknown. This study aimed to determine whether new pulmonary lesions will develop after treatment in patients with COVID-19 pneumonia, and investigate their CT features and outcomes. Methods: This retrospective study included 56 consecutive patients with confirmed COVID-19 pneumonia from January 20 to March 5, 2020. Their initial and follow-up CT images and clinical data were reviewed. The CT manifestations of primary and newly developed pulmonary lesions and their changes after treatment were mainly evaluated. Results: Among the 56 patients (mean age: 48±15 years, 35 men) with COVID-19 pneumonia, 42 (75.0%) patients developed new pulmonary lesions during treatment. All new lesions developed before the nucleic acid test turned negative. Patients with new lesions were more likely to have lymphopenia (P=0.041) or increased C-reactive protein (CRP) levels (P<0.001) than those without new lesions. Of the 42 patients, 30 (71.4%) patients developed new lesions once, and 12 (28.6%) twice or thrice, which usually appeared when primary lesions were progressing (37, 88.1%) and 1-15 days after treatment. The newly developed lesions were usually multiple (38, 90.5%), distributed in the previously involved (39, 92.9%) or uninvolved (27, 64.3%) lobes, and manifested as ground-glass opacities (GGOs) with consolidation (23, 54.8%) or pure GGOs (19, 45.2%). After their occurrence, the new lesions in most patients (32, 76.2%) showed direct absorption, whereas those in some patients (10, 23.8%) progressed before absorption. Conclusion: During treatment, most patients with COVID-19 pneumonia will develop new pulmonary lesions, which usually manifest as multiple GGOs distributed around the primary lesions or in previously uninvolved lobes, and are subsequently absorbed directly.

References Powered by Scopus

A novel coronavirus from patients with pneumonia in China, 2019

20123Citations
N/AReaders
Get full text

Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China

17187Citations
N/AReaders
Get full text

Characteristics of and Important Lessons from the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases from the Chinese Center for Disease Control and Prevention

13488Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Li, W. J., Lv, Z. M., Lv, F. J., Fu, B., Hu, L. B., & Chu, Z. G. (2020). CT features and outcomes of newly developed pulmonary lesions in patients with coronavirus disease 2019 (COVID-19). International Journal of Medical Sciences, 17(15), 2373–2378. https://doi.org/10.7150/ijms.47587

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 7

64%

Researcher 4

36%

Readers' Discipline

Tooltip

Medicine and Dentistry 11

69%

Pharmacology, Toxicology and Pharmaceut... 2

13%

Environmental Science 2

13%

Nursing and Health Professions 1

6%

Save time finding and organizing research with Mendeley

Sign up for free